期刊文献+

RNA干扰趋化因子受体4基因表达对神经母细胞瘤体外侵袭能力的影响 被引量:6

Knockdown of chemokine receptor type 4 (CXCR4) expression blocks neuroblastoma metastasis by RNA interference
原文传递
导出
摘要 目的构建趋化因子受体4(Q(cR4)小分子干扰RNA(siRNA)表达载体,研究其对体外神经母细胞瘤侵袭能力的影响。方法选择CXCR4高表达的神经母细胞瘤SH-SY5Y细胞系,设计合成人CXCR4基因不同靶点的能编码siRNA的3条双链DNA序列,克隆到真核表达载体pSilencer^TMneo中构建siRNA表达载体,体外脂质体介导转染SH-SY5Y细胞,用半定量RT-TCR分析CXCR4基因mRNA的变化,用免疫组织化学和Westernblot分析CXCR4蛋白表达,Transwell小室检测细胞的侵袭能力。结果成功构建了CXCR4-siRNA表达载体,转染后半定量RT-PCR检测神经母细胞瘤细胞CXCR4mRNA丰度分别为siR1转染组0.32±0.09、siR2转染组0.35±0.13和siR3转染组0.33±0.11,相对于对照组0.58±0.13表达下降(P〈0.05);转染后免疫组化检测神经母细胞瘤细胞CXCR4的蛋白表达分别为siR1转染组75.98±4.81、siR2转染组75.52±3.95和siR3转染组76.35±6.51,相对于对照组92.196±3.89表达下降(P〈0.01);转染后Western blot检测神经母细胞瘤细胞CXCR4的蛋白表达分别为siRl转染组0.1103±0.0023、siR2转染组0.1203±0.0015和siR3转染组0.1308±0.0018,相对于对照组0.4832±0.0012表达下降(P〈0.01);且转染后神经母细胞瘤细胞侵袭能力较对照组53.11±3.72降低(P〈0.05),siR1转染组为25.48±2.81、siR2转染组为30.89±2.77、siR3转染组为18.83±1.79。结论CXCR4-siRNA表达载体通过降低CXCR4基因的蛋白表达能显著抑制神经母细胞瘤细胞的体外侵袭能力,有望为神经母细胞瘤的基因治疗开辟新途径。 Objective To explore the effect of silencing chemokine receptor type 4 (CXCR4) by siRNA on the invasion capability of neuroblastoma cell line SH-SYSY in vitro. Methods Three siRNAs targeting CXCR4 were chemically synthesized and transfected into SH-SY5Y cells. The transfection efficiency was observed under fluorescence microscope. CXCR4 expression at mRNA and protein levels were detected by semi-quantitative RT-PCR and Western blotting. The invasion capability of the cells was evaluated by Boyden Chamber in vitro. Results Compared with control groups, after the SH-SY5Y cells being transfected with the three CXCR4 targeting siRNAs, CXCR4 mRNA in transfected cells significantly decreased (0. 32 ± 0. 09, 0. 35 ± 0. 13 and 0.33 ± 0. 11 vs 0. 58 ±0. 13, P〈 0. 05), CXCR4 protein detected by immunohistochemistry was decreased (75.98 ± 4. 81, 75. 52 ± 3. 95 and 76. 35 ± 6. 51 vs 92. 196 ± 3.89, P〈0. 01 ), CNCR4 protein detected by Western blotting was also decreased (0. 1103 ±0. 0023, 0. 1203± 0. 0015 and 0. 1308 ± 0. 0018 vs 0. 4832 ± 0. 0012, P〈0. 01). The invasion capability of the SH-SY5Y cells was decreased 48 hours after the cells were transfeeted (25.48±2.81, 30.89±2.77 and 18.83±1.79 vs 53.11±3.72, P〈0.05). Conclusions Silencing CXCR4 by siRNA decreases the invasion capability of SH-SY5Y cells.
出处 《中华小儿外科杂志》 CSCD 北大核心 2011年第4期285-289,共5页 Chinese Journal of Pediatric Surgery
基金 国家自然科学基金资助(编号:30872702),2007年青岛市科技发展计划(编号:07-2-15-nsh)
关键词 受体 趋化因子 RNA干扰 神经母细胞瘤 Receptors, chemokine RNA interference Neuroblastoma
  • 相关文献

参考文献2

二级参考文献36

  • 1高强,董蒨,鹿洪亭,罗兵,吕振华,孙丽荣.神经母细胞瘤体外细胞系的构建方法[J].山东医药,2004,44(21):3-4. 被引量:6
  • 2Redlinger RE Jr, Mailliard RB, Barksdale EM Jr. Neuroblastoma and dendritic cell function. Semin Pediatr Surg, 2004,13: 61-71.
  • 3Bogenmann E, Peterson S, Maekawa K, et al. Regulation of NGF responsiveness in human neuroblastoma. Oncogene, 1998,17: 2367-2376.
  • 4Azar C,Scavarda NJ,Reynold CP, et al. Multiple defects of the never growth factor receptor in human neuroblastomas. Prog Clinbiol Res, 1991,366:219-226.
  • 5司徒镇强 吴军正.细胞培养[Z].西安:世界图书出版公司,1999.71-72.
  • 6Flanagan SP. Nude a new hairless gene with pleicfropic in the mouse. Genet Res Camb, 1986,8 ( 3 ): 295.
  • 7Scotton C J, Wilson J L, Scott K, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer [J]. Cancer Res, 2002,62(20) :5930-5938.
  • 8Sun Y X, Wang J, Shelburne C E,et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo [J]. J Cell Biochem, 2003,89 (3): 462-473.
  • 9Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor lalpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt [J]. Cancer Res, 2003,63(8) : 1969-1974.
  • 10Darash-Yahana M, Pikarsky E,Abramovitch R, et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis[J]. FASEB J, 2004,8(11):1240-1242.

共引文献35

同被引文献69

  • 1郝希伟,董蒨,鹿洪亭,吕振华,孙立荣,江布先.神经母细胞瘤荷瘤鼠模型建立的实验研究[J].中华小儿外科杂志,2005,26(7):372-375. 被引量:16
  • 2龚振华,川村健児,栗山裕.神经母细胞瘤的综合治疗[J].临床小儿外科杂志,2005,4(2):81-84. 被引量:4
  • 3蒋玉萍,吴小华.趋化因子CXCL12及其受体与肿瘤转移的关系[J].癌症,2007,26(2):220-224. 被引量:21
  • 4罗远建,金科,甘青,刘金桥.儿童神经母细胞瘤的影像学表现[J].临床小儿外科杂志,2007,6(2):51-53. 被引量:12
  • 5Qian D, Qiang G, Hongting L. Differentiation of neuroblastoma cell induced by never growth factor gene transfaction . World J Pediator,2007,3(2): 115- 120.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer,2006,6(11) :857-866.
  • 7Guo J, Dong Q, Fang Z, et al. Identification of miRNAs that are associated with tumor metastasis in neurohlastoma. Cancer Biol Ther,2010,9(6) :446-452.
  • 8Livak KJ, Sehmittgen TD. Analysis of relative gene expression data U-sing real-time quantitative PCR and the 2^-ΔΔCT methods. Methods, 2001,25 (4) : 402-408.
  • 9Calin GA, Sevignani C, Dumitru CD,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad Sci USA,2004, 101 (9): 2999-3004.
  • 10Zhang B, Pan X, Cobb GP, et al. mieroRNAs as oneogenes and tumor suppressors. Dev Biol. 2007 , 302 (1) : 1-12.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部